Back to Trades
Sell4
GILEAD SCIENCES, INC.
GILD
Total Value
$1.4M
Net $1.4M sold
Sales
$1.4M
3 transactions
Company Information
- Company Name
- GILEAD SCIENCES, INC.
- Ticker Symbol
- GILD
- CIK
- 0000882095
Insider Information
- Role
- Chairman & CEO, Director
- Location
- FOSTER CITY, CA
DirectorOfficer
Filing Details
- Filing Date
- Mar 2, 2026
- Transaction Date
- Feb 27, 2026
- Accession Number
- 0001638643-26-000012
- Form Type
- 4
- Net Trading Amount
- -$1.4M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Feb 27, 2026 | Common Stock | 38,396 | — | Grant/Award | — |
| Feb 27, 2026 | Common Stock | 3,481 | $144.04 | Sale | $501.4K |
| Feb 27, 2026 | Common Stock | 6,419 | $145.18 | Sale | $931.9K |
| Feb 27, 2026 | Common Stock | 100 | $145.71 | Sale | $14.6K |
Footnotes
- (F1)Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2025. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors.
- (F2)The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025.
- (F3)Sale prices for the transactions reported range from $143.63 to $144.59. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
- (F4)Sale prices for the transactions reported range from $144.66 to $145.65. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.